Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign
The American Journal of Tropical Medicine and Hygiene · 2024
DOI: 10.4269/ajtmh.24-0181 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Kashmira Date und 29 weiteren Autor:innen. Beteiligte Einrichtung: Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia. Hauptthemen laut MEDLINE: Typhoid-Paratyphoid Vaccines, Typhoid Fever, Vaccines, Conjugate. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, FIC NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Typbar-TCV ® , a typhoid conjugate vaccine (TCV), was prequalified by the World Health Organization in 2017. We evaluated its effectiveness in a mass vaccination program targeting children 9 months to 14 years in Navi Mumbai, India, from September 2018 to July 2020. We compared laboratory-confirmed typhoid cases from six clinical sites with age-matched community controls. Of 38 cases, three (8.6%) received TCV through the campaign, compared with 53 (37%) of 140 controls. The adjusted odds ratio of typhoid fever among vaccinated children was 0.16 (95% CI: 0.05–0.55), equivalent to a vaccine effectiveness of 83.7% (95% CI: 45.0–95.3). Vaccine effectiveness of Typbar-TCV in this large public sector vaccine introduction was similar to prior randomized controlled trials, providing reassurance to policymakers that TCV effectiveness is robust in a large-scale implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California.
- Ministry of Health & Family Welfare, Government of India, New Delhi, India.
- World Health Organization-Country Office for India, National Public Health Surveillance Project, New Delhi, India.
- Dr. Yewale Multispecialty Hospital for Children, Navi Mumbai, India.
- Department of Pediatrics, NMMC General Hospital, Navi Mumbai, India.
Förderung
- World Health Organization
- FIC NIH HHS
- NIAID NIH HHS
Zitieren
APA
Date, K., LeBoa, C., Hoffman, S. A., Haldar, P., Harvey, P., An, Q., Zhang, C., Yewale, V. N., Daruwalla, S., Dharmapalan, D., Gavhane, J., Joshi, S., Rai, R., Rathod, V., Shetty, K., Warrier, D. S., Yadav, S., Shimpi, R., Jayaprasad, N., …, & Luby, S. P. (2024). Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.24-0181
Vancouver
Date K, LeBoa C, Hoffman SA, Haldar P, Harvey P, An Q, et al. Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.24-0181
BibTeX
@article{Date2024,
author = {Date, Kashmira and LeBoa, Christopher and Hoffman, Seth A and Haldar, Pradeep and Harvey, Pauline and An, Qian and Zhang, Chenhua and Yewale, Vijay N and Daruwalla, Savita and Dharmapalan, Dhanya and Gavhane, Jeetendra and Joshi, Shrikrishna and Rai, Rajesh and Rathod, Varsha and Shetty, Keertana and Warrier, Divyalatha S and Yadav, Shalini and Shimpi, Rahul and Jayaprasad, Niniya and Horng, Lily and Fagerli, Kirsten and Borhade, Priyanka and Chakraborty, Debjit and Katkar, Arun and Kunwar, Abhishek and Andrews, Jason R and Bahl, Sunil and Bhatnagar, Pankaj and Dutta, Shanta and Luby, Stephen P},
title = {Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2024},
doi = {10.4269/ajtmh.24-0181}
}
EUVIMED